Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.42 |
| ▸ | TAS1R2 | Q8TE23 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.41 |
| ▸ | TPMT | P51580 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2648126 | 0.85 | CYP3A4 (0.54) | HPGDKMT2AMEN1CYP3A4SMN1; SMN2 | |
| SCHEMBL30597490 | 0.85 | CYP3A4 (0.54) | HPGDKMT2AMEN1CYP3A4SMN1; SMN2 | |
| SCHEMBL16976467 | 0.84 | KDM4E (0.39) | KDM4EHPGDKMT2AMEN1CYP3A4 | |
| SCHEMBL10101636 | 0.82 | GAA (0.44) | KDM4EHPGDKMT2AMEN1CYP3A4 | |
| SCHEMBL27964400 | 0.82 | KDM4E (0.57) | KDM4EHPGDCYP3A4ALDH1A1L3MBTL1 | |
| SCHEMBL2380154 | 0.81 | CYP3A4 (0.61) | HPGDKMT2AMEN1CYP3A4ALDH1A1 | |
| SCHEMBL16644713 | 0.80 | CYP3A4 (0.55) | KMT2ACYP3A4ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL2380706 | 0.80 | SMN1; SMN2 (0.44) | HPGDCYP3A4ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL6666412 | 0.80 | HPGD (0.52) | KDM4EHPGDKMT2AMEN1CYP3A4 | |
| SCHEMBL22109937 | 0.80 | HPGD (0.47) | KDM4EHPGDKMT2AMEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 366 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116410077-A | Preparation method of 2,4, 6-trimethyl benzoic acid | 甘肃青宇新材料有限公司 | 2023-07-11 | — | — | CN | claimed |
| CN-108906124-B | Application of rare earth metal tricyclocene complex as catalyst in catalysis of synthesis reaction of ketone and pinacol borane | 苏州大学 | 2020-11-17 | — | — | CN | claimed |
| US-9174906-B2 | Process for producing optically active secondary alcohol | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2015-11-03 | — | — | US | claimed |
| US-6833468-B2 | Reacting an optically active imine with a compound that is a hemiacetal of a perfluoroalkylaldehyde or a hydrate of a perfluoroalkylaldehyde to obtain a condensate, hydrolyzing | CENTRAL GLASS COMPANY, LIMITED (JP) | 2004-12-21 | — | — | US | claimed |
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | claimed |
| US-5928765-A | Recording sheets | XEROX CORPORATION (US) | 1999-07-27 | — | — | US | claimed |
| EP-0674233-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| WO-1991010635-A1 | PROCESS FOR PREPARING 2,4,6-TRIMETHYLACETOPHENONE | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-07-25 | — | — | WO | claimed |
| EP-0043480-B1 | PROCESS FOR FORMING METALLIC IMAGES | Hitachi, Ltd. (JP) | 1985-04-03 | — | — | EP | claimed |
| US-4347304-A | PHOTOSENSITIZATION WITH DISILANES OR ORGANIC COMPOUNDS HAVING COUPLED GERMANIUM OR TIN MOLECULES; PHOTORESISTS; POSITIVES; PLATING | HITACHI, LTD. (JP) | 1982-08-31 | — | — | US | claimed |
| EP-3990503-B1 | OLEFIN POLYMERIZATION CATALYSTS BEARING A THIAZOLE OR IMIDAZOLE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-07-23 | — | — | EP | disclosed |
| US-12286502-B2 | Olefin polymerization catalysts bearing a thiazole or imidazole | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-04-29 | — | — | US | disclosed |
| US-12042788-B2 | Strongly Lewis acidic metal-organic frameworks for continuous flow catalysis | THE UNIVERSITY OF CHICAGO (US) | 2024-07-23 | — | — | US | disclosed |
| EP-3605093-B1 | KIT AND METHOD FOR MEASURING MEASUREMENT TARGET SUBSTANCE IN BIOLOGICAL SAMPLE | FUJIFILM CORP (JP) | 2024-07-17 | — | — | EP | disclosed |
| CN-116964139-B | Photoinitiator resin with dibenzoylmethane substructure | 太阳化学有限公司 | 2024-07-12 | — | — | CN | disclosed |
| US-3987082-A | PROSTAGLANDIN INTERMEDIATE | MERCK & CO., INC. (US) | 1976-10-19 | — | — | US | disclosed |
| US-3975373-A | CYCLOPENTANONE HELVETICOSIDE | JOHANN A. WULFING FABRIK PHARMAZEUTISCHER PRAPARATE (DT) | 1976-08-17 | — | — | US | disclosed |
| US-3971825-A | (5,6) (10,11) BIS-METHYLENE, BRONCHODILATORS | SANKYO COMPANY LIMITED (JA) | 1976-07-27 | — | — | US | disclosed |
| US-3951946-A | Cardioglycoside derivatives of the strophanthidin type, a process for their manufacture and medicinal preparations containing these compounds | JOHANN A. WULFING FABRIK PHARMAZEUTISCHER PRAPARATE (DT) | 1976-04-20 | — | — | US | disclosed |
| US-3950359-A | PROSTAGLANDINS AND METHODS OF MAKING SAME | MERCK & CO., INC. (US) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12042788-B2 | Strongly Lewis acidic metal-organic frameworks for continuous flow catalysis | CD69, TECR, MCM4 | KDM4E 1059/4885HPGD 945/4885KMT2A 1213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.